Cargando…

Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment

Intermittent hypoxia (IH) has a dual nature. On the one hand, chronic IH (CIH) is an important pathologic feature of obstructive sleep apnea (OSA) syndrome (OSAS), and many studies have confirmed that OSA-related CIH (OSA-CIH) has atherogenic effects involving complex and interacting mechanisms. Lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Binyu, Li, Yiwen, Zhu, Mengmeng, Cui, Jing, Liu, Yanfei, Liu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365608/ https://www.ncbi.nlm.nih.gov/pubmed/35965683 http://dx.doi.org/10.1155/2022/1438470

Ejemplares similares

Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
por: Zhu, Mengmeng, et al.
Publicado: (2022)

The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights
por: Li, Yiwen, et al.
Publicado: (2022)

Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective
por: Ma, Linqin, et al.
Publicado: (2016)

Monosodium Glutamate-Induced Mouse Model With Unique Diabetic Retinal Neuropathy Features and Artificial Intelligence Techniques for Quantitative Evaluation
por: Liu, Yanfei, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach
por: Tian, Jinfan, et al.
Publicado: (2017)

Dietary patterns and cardiometabolic health: Clinical evidence and mechanism
por: Wang, Wenting, et al.
Publicado: (2023)

Influence of Intermittent Hypoxia/Hypercapnia on Atherosclerosis, Gut Microbiome, and Metabolome
por: Xue, Jin, et al.
Publicado: (2021)

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
por: Li, Yiwen, et al.
Publicado: (2023)

Brown Adipose Tissue Activation Is Involved in Atherosclerosis of ApoE(−/−) Mice Induced by Chronic Intermittent Hypoxia
por: Wang, Yue, et al.
Publicado: (2021)

Editorial: Intermittent Hypoxia: From Basic Mechanisms to Clinical Insights and Therapeutics
por: Lavie, Lena
Publicado: (2020)

Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota
por: Hu, Chaowei, et al.
Publicado: (2021)

Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression
por: Zeng, Xianqin, et al.
Publicado: (2018)

Intermittent Hypoxia Composite Abnormal Glucose Metabolism-Mediated Atherosclerosis In Vitro and In Vivo: The Role of SREBP-1
por: Ma, Linqin, et al.
Publicado: (2019)

Mechanisms of intermittent hypoxia induced hypertension
por: Bosc, Laura V González, et al.
Publicado: (2010)

Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis
por: Zhang, Jing, et al.
Publicado: (2020)

Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
por: Gualtierotti, Roberta, et al.
Publicado: (2023)

Hypobaric Intermittent Hypoxia Attenuates Hypoxia-induced Depressor Response
por: Cui, Fang, et al.
Publicado: (2012)

Correction: Hypobaric Intermittent Hypoxia Attenuates Hypoxia-induced Depressor Response
por: Cui, Fang, et al.
Publicado: (2013)

Signalling mechanisms of long term facilitation of breathing with intermittent hypoxia
por: Pamenter, Matthew E, et al.
Publicado: (2013)

The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
por: Sun, Yu, et al.
Publicado: (2022)

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Intermittent Hypoxia in Childhood: The Harmful Consequences Versus Potential Benefits of Therapeutic Uses
por: Serebrovskaya, Tatiana V., et al.
Publicado: (2015)

Intermittent Hypoxia as a Therapeutic Tool to Improve Health Parameters in Older Adults
por: Timon, Rafael, et al.
Publicado: (2022)

Intermittent Hypoxia Conditioning: A Potential Multi-Organ Protective Therapeutic Strategy
por: Zhang, Qihan, et al.
Publicado: (2023)

Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
por: Wang, Jun, et al.
Publicado: (2022)

Inhibition of Vascular Endothelial Cadherin Cleavage Prevents Elastic Fiber Alterations and Atherosclerosis Induced by Intermittent Hypoxia in the Mouse Aorta
por: Harki, Olfa, et al.
Publicado: (2022)

Distinct Mechanisms Underlying Tolerance to Intermittent and Constant Hypoxia in Drosophila melanogaster
por: Azad, Priti, et al.
Publicado: (2009)

Cardioprotective Antioxidant and Anti-Inflammatory Mechanisms Induced by Intermittent Hypobaric Hypoxia
por: González-Candia, Alejandro, et al.
Publicado: (2022)

New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
por: Liu, Yanfei, et al.
Publicado: (2019)

Intermittent hypoxia treatments cause cellular priming in human microglia
por: De Felice, Martina, et al.
Publicado: (2023)

Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

Intermittent hypoxia produces Alzheimer disease?
por: Yagishita, Sosuke, et al.
Publicado: (2017)

The Impact of Intermittent Hypoxia on Metabolism and Cognition
por: Shobatake, Ryogo, et al.
Publicado: (2022)

Atherosclerosis: From Molecular Biology to Therapeutic Perspective
por: Perrotta, Ida
Publicado: (2022)

Mild intermittent hypoxia exposure induces metabolic and molecular adaptations in men with obesity
por: van Meijel, Rens L.J., et al.
Publicado: (2021)

Intermittent Fasting Inhibits High-Fat Diet–Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction
por: Chen, Yuanli, et al.
Publicado: (2021)

Pathogenesis of Abnormal Hepatic Lipid Metabolism Induced by Chronic Intermittent Hypoxia in Rats and the Therapeutic Effect of N-Acetylcysteine
por: Wang, Haipeng, et al.
Publicado: (2018)

Involvement of Hepcidin in Cognitive Damage Induced by Chronic Intermittent Hypoxia in Mice
por: Zhao, Ya-Shuo, et al.
Publicado: (2021)

Hypoxia/reperfusion predisposes to atherosclerosis
por: Finsterwalder, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_402d05ladjp2o7cb4v8ap2q4v6